
Aarti Industries Q4 Results FY26 PAT Rs 137 Crore FY26 Revenue Rs 9018 Crore Up 12 Percent
Tue May 05 2026

Aarti Industries Q4 results for FY26 delivered a quarterly consolidated net profit of Rs 137 crore on total income of Rs 2,205 crore. The Aarti Industries Q4 results cap a fiscal year where full-year PAT rose 27% year on year to Rs 419 crore, annual revenue grew 12% to Rs 9,018 crore, and EBITDA improved 15% to Rs 1,172 crore — the first time the company has crossed Rs 9,000 crore in annual revenue.
The Aarti Industries Q4 results were delivered against a challenging macro environment where the US-Iran conflict disrupted global chemical supply chains and the Iranian specialty chemical export market saw significant dislocation. CEO Suyog Kotecha stated the company responded by rerouting volumes from disrupted regions, demonstrating the diversification strength underpinning the Aarti Industries Q4 results.
Get Free Stock Recommendations on Univest
Aarti Industries Q4 FY26 Results at a Glance
| Metric | Q4 FY26 | Change / Context |
|---|---|---|
| Q4 Net Profit PAT | Rs 137 crore | vs Rs 133 crore in Q3 FY26 |
| Q4 Total Income | Rs 2,205 crore | vs Rs 2,321 crore in Q3 FY26 |
| Q4 EBITDA | Rs 342 crore | vs Rs 323 crore in Q3 FY26 |
| FY26 Annual Revenue | Rs 9,018 crore | +12% YoY |
| FY26 EBITDA | Rs 1,172 crore | +15% YoY |
| FY26 PAT | Rs 419 crore | +27% YoY |
| FY26 EPS | Rs 11.55 | vs Rs 9.12 in FY25 |
| Dividend | Rs 1 per share | FY26 recommendation |
| FY28 EBITDA Target | Rs 1,800-2,200 crore | Management guidance |
Track live Aarti Industries financials, analyst ratings and peer comparisons on the Univest Screener.
Key Highlights from Aarti Industries Q4 FY26 Results
FY26 Annual PAT Up 27 Percent Confirms Specialty Chemicals Recovery
The full-year performance embedded in the Aarti Industries Q4 results is the more significant data point. Annual PAT of Rs 419 crore rising 27% year on year demonstrates the specialty chemicals upcycle turning positive after a period of compressed margins. FY26 EBITDA of Rs 1,172 crore up 15% on 12% revenue growth confirms operating leverage across the NCB, DCB, and Nitro Toluene value chains.
FY28 EBITDA Target of Rs 1800 to 2200 Crore Set in Aarti Industries Q4 Results Commentary
CEO Suyog Kotecha set an ambitious FY28 EBITDA target of Rs 1,800 to 2,200 crore in the Aarti Industries Q4 results commentary — nearly double FY26 EBITDA of Rs 1,172 crore. This is to be driven by commissioning of MPP and Zone 4 facilities, a DCA downstream JV with Superform expected to commission in H1 FY27, and the Re Aarti chemical recycling of plastics initiative expected in CY26. MMA capacity is being expanded from 200 kTPA to 290 kTPA with further plans to 360 kTPA.
What Drove Aarti Industries Q4 FY26 Performance
The Aarti Industries Q4 results performance was driven by stable domestic demand, strong export volumes rerouted from US-Iran conflict-affected regions, and operating discipline across facilities. The NCB and DCB value chains benefited from import substitution as global supply chain disruptions reduced Chinese competition in certain export corridors. FY26 capex of approximately Rs 1,125 crore funded capacity expansions that are expected to drive FY27 and FY28 revenue ramp-up.
Dividend and Capital Allocation
The board recommended a dividend of Rs 1 per share as part of the Aarti Industries Q4 results FY26. The modest payout reflects the company’s capital allocation priority toward funding the FY28 EBITDA target. New capacity additions including the expanding MMA plant and upcoming MPP and Zone 4 facilities require significant ongoing capital deployment.
Outlook for FY27
Following the Aarti Industries Q4 results, FY27 is expected to see the DCA JV with Superform commission in H1 and the MMA plant contribute incremental volumes. Management’s FY28 EBITDA target of Rs 1,800 to 2,200 crore implies approximately 25% CAGR from FY26 levels, making the Aarti Industries Q4 results the base for a potential significant earnings re-rating.
Conclusion
The Aarti Industries Q4 results FY26 confirm a company transitioning from recovery to earnings acceleration. FY26 PAT Rs 419 crore up 27%, revenue Rs 9,018 crore up 12%, and an ambitious FY28 EBITDA target of Rs 1,800 to 2,200 crore collectively signal the multi-year capex programme is nearing commercialisation. Investors monitoring the Aarti Industries Q4 results should watch the DCA JV commissioning and MMA capacity ramp-up as primary FY27 value catalysts.
Download the Univest iOS App or Univest Android App for live Q4 results tracking and expert research.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making investment decisions.
Frequently Asked Questions
What was Aarti Industries Q4 FY26 net profit?
Aarti Industries Q4 results FY26 reported quarterly PAT of Rs 137 crore on total income of Rs 2,205 crore. FY26 full-year PAT grew 27% to Rs 419 crore. The board also recommended a dividend of Rs 1 per share for FY26.
What is Aarti Industries FY26 annual revenue?
Aarti Industries Q4 results FY26 confirmed annual revenue of Rs 9,018 crore, up 12% year on year — the first time the company has crossed the Rs 9,000 crore mark. FY26 EPS rose to Rs 11.55 from Rs 9.12 in FY25.
What is Aarti Industries FY28 EBITDA target?
The Aarti Industries Q4 results management commentary set a FY28 EBITDA target of Rs 1,800 to 2,200 crore, approximately double the FY26 EBITDA of Rs 1,172 crore. This is driven by new MPP and Zone 4 capacity, the DCA JV with Superform in H1 FY27, and Re Aarti recycling in CY26.
What dividend did Aarti Industries declare for FY26?
Aarti Industries Q4 results FY26 included a board recommendation of Rs 1 per share dividend for FY26. The modest payout reflects capital retention for the multi-year capacity expansion programme targeting FY28 EBITDA of Rs 1,800 to 2,200 crore.
Recent Article
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026
Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026
Related Posts
Abbott India Share Price Falling: Key Reasons, Analysis and 2026 Recovery Outlook
Avantel Share Price Falling: Key Reasons, Analysis and 2026 Recovery Outlook
Greenlam Industries Share Price Falling: Key Reasons, Analysis and 2026 Recovery Outlook
CEAT Share Price Falling: Key Reasons, Analysis and 2026 Recovery Outlook
Sanofi India Share Price Falling: Key Reasons, Analysis and 2026 Recovery Outlook

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →